Acetylcholinesterase Inhibitors: Treatment of Dementia-Related Behavioral Disturbances.
作者信息
Gupta Sanjay, Masand Prakash, Virk Subhdeep
机构信息
Olean General Hospital, Olean, New York.
出版信息
Prim Care Companion J Clin Psychiatry. 2000 Dec;2(6):227-228. doi: 10.4088/pcc.v02n0607.
Abstract
摘要
相似文献
1
Acetylcholinesterase Inhibitors: Treatment of Dementia-Related Behavioral Disturbances.乙酰胆碱酯酶抑制剂：治疗与痴呆相关的行为障碍
Prim Care Companion J Clin Psychiatry. 2000 Dec;2(6):227-228. doi: 10.4088/pcc.v02n0607.
2
Use of acetylcholinesterase inhibitors in Alzheimer's disease.乙酰胆碱酯酶抑制剂在阿尔茨海默病中的应用。
Expert Rev Neurother. 2001 Sep;1(1):61-9. doi: 10.1586/14737175.1.1.61.
3
A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders.卡巴拉汀治疗痴呆及其他神经系统疾病行为障碍有效性的系统评价
Curr Med Res Opin. 2008 Jan;24(1):157-66. doi: 10.1185/030079908x260961.
4
5
Psychotropic medication use for behavioral symptoms of dementia.用于治疗痴呆行为症状的精神药物
Curr Neurol Neurosci Rep. 2006 Nov;6(6):490-5. doi: 10.1007/s11910-006-0051-6.
6
Contribution of psychosis and depression to behavioral disturbances in geropsychiatric inpatients with dementia.精神病和抑郁症对老年痴呆症老年精神科住院患者行为障碍的影响。
J Gerontol A Biol Sci Med Sci. 1999 Mar;54(3):M157-61. doi: 10.1093/gerona/54.3.m157.
7
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.卡巴拉汀：乙酰胆碱酯酶和丁酰胆碱酯酶双重抑制的优势及其在皮质下血管性痴呆和帕金森病痴呆中的作用。
Clin Interv Aging. 2017 Apr 18;12:697-707. doi: 10.2147/CIA.S129145. eCollection 2017.
8
Behavioral disturbances of dementia: an overview of phenomenology and methodologic concerns.痴呆的行为障碍：现象学与方法学问题概述
Int Psychogeriatr. 1996;8 Suppl 2:169-80; discussion 181-2. doi: 10.1017/s1041610297003335.
9
Behavioral Disturbances in Dementia and Beyond: Time for a New Conceptual Frame?痴呆及其他疾病相关的行为障碍：是否需要新的概念框架？
Int J Mol Sci. 2019 Jul 25;20(15):3647. doi: 10.3390/ijms20153647.
10
Behavioral disturbances in the course of frontotemporal dementia.额颞叶痴呆病程中的行为障碍
Dement Geriatr Cogn Disord. 2006;22(4):352-7. doi: 10.1159/000095625. Epub 2006 Sep 4.
本文引用的文献
1
Cholinesterase inhibitors: A new class of psychotropic compounds.胆碱酯酶抑制剂：一类新型精神药物化合物。
Am J Psychiatry. 2000 Jan;157(1):4-15. doi: 10.1176/ajp.157.1.4.
2
The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease.阿尔茨海默病中胆碱酯酶抑制剂治疗的行为反应谱。
Arch Neurol. 1999 Nov;56(11):1388-93. doi: 10.1001/archneur.56.11.1388.
3
Treatment of agitation in dementia.痴呆症中激越行为的治疗。
J Clin Psychiatry. 1999;60 Suppl 8:11-20.
4
Behavioral disturbances of dementia.
J Geriatr Psychiatry Neurol. 1998 Winter;11(4):206-12. doi: 10.1177/089198879901100407.
5
Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
JAMA. 1998 Nov 25;280(20):1777-82. doi: 10.1001/jama.280.20.1777.
6
Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.阿尔茨海默病中与治疗相关的行为变化评估及神经精神症状的胆碱能治疗
J Clin Psychiatry. 1998;59 Suppl 13:23-30.
7
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.一项针对阿尔茨海默病患者的多奈哌齐24周双盲安慰剂对照试验。多奈哌齐研究组。
Neurology. 1998 Jan;50(1):136-45. doi: 10.1212/wnl.50.1.136.
8
Butyrylcholinesterase in the life cycle of amyloid plaques.淀粉样斑块生命周期中的丁酰胆碱酯酶
Ann Neurol. 1997 Dec;42(6):909-18. doi: 10.1002/ana.410420613.
9
The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.多奈哌齐治疗阿尔茨海默病患者的疗效和安全性：一项美国多中心、随机、双盲、安慰剂对照试验的结果。多奈哌齐研究组
Dementia. 1996 Nov-Dec;7(6):293-303. doi: 10.1159/000106895.
Zotero 插件